Filing Flows › Constellium SE (CSTM) › Stock forecast & fair value
Constellium SE (CSTM) stock forecast and fair value
Constellium SE (CSTM) trades at $21.91. 6 analysts' median price target is $33.99 (+55%), from $29.99 to $35.99. Across 21 valuation methods the middle fair value is $63.00 (+188%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $49.51 | $78.61 | $97.76 | +259% |
| P/E vs peers, weighted | $67.07 | $100.19 | $209.24 | +357% |
| P/E vs peers, matched | $43.65 | $76.18 | $100.38 | +248% |
| EV/Sales vs peers | $42.60 | $93.55 | $141.49 | +327% |
| EV/Sales vs peers, weighted | $81.69 | $121.04 | $375.59 | +452% |
| EV/Sales vs peers, matched | $42.40 | $101.69 | $145.12 | +364% |
| Residual income | $23.24 | $24.14 | $25.08 | +10% |
| Sum of the parts (segments × peer EV/Sales) | $58.97 | $115.85 | $277.92 | +429% |
| Sum of the parts, weighted (segments × weighted peer EV/Sales) | $86.78 | $127.49 | $441.94 | +482% |
| Analysts' price targets | $29.99 | $33.48 | $35.99 | +53% |
Constellium SE's latest quarter
Constellium SE, Q3 2026: revenue $2.6B (+22% year over year), operating margin 6.1%, net earnings $119M, operating cash flow $186M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CSTM stock?
The median of 6 analysts' 12-month targets is $33.99, +55% from $21.91; the range is $29.99 to $35.99. The average rating is strong buy.
What is Constellium SE's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $9.63 and $127.49, with a middle value of $63.00 against a price of $21.91. Each method's assumptions are on the page.
Does Constellium SE usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is CSTM stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.